nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abnormal bile acid-microbiota crosstalk promotes the development of hepatocellular carcinoma
|
Shen, Rui |
|
|
16 |
2 |
p. 396-411 |
artikel |
2 |
Alterations of gut microbiome and metabolite profiles in choledocholithiasis concurrent with cholangitis
|
Hao, Zhiyuan |
|
|
16 |
2 |
p. 447-462 |
artikel |
3 |
A novel machine learning-based radiomic model for diagnosing high bleeding risk esophageal varices in cirrhotic patients
|
Yan, Yijie |
|
|
16 |
2 |
p. 423-432 |
artikel |
4 |
Are immune-checkpoint inhibitors immunosuppressive to hepatitis B virus?
|
Lau, George |
|
|
16 |
2 |
p. 482-483 |
artikel |
5 |
Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy
|
Kumar, Manoj |
|
|
16 |
2 |
p. 211-253 |
artikel |
6 |
Carbohydrate-deficient transferrin is a sensitive marker of alcohol consumption in fatty liver disease
|
Morinaga, Maki |
|
|
16 |
2 |
p. 348-358 |
artikel |
7 |
Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
|
Hartmann, Phillipp |
|
|
16 |
2 |
p. 359-370 |
artikel |
8 |
Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy
|
Lau, George |
|
|
16 |
2 |
p. 486-487 |
artikel |
9 |
Correction to: Consensus on the secondary prevention of primary liver cancer
|
Nan, Yuemin |
|
|
16 |
2 |
p. 484-485 |
artikel |
10 |
Correction to: The association between metabolic risk factors, nonalcoholic fatty liver disease, and the incidence of liver cancer: a nationwide population-based cohort study
|
Chen, Yu-Guang |
|
|
16 |
2 |
p. 488 |
artikel |
11 |
Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV–DNA level < 2000 IU/mL
|
Lee, Hankil |
|
|
16 |
2 |
p. 294-305 |
artikel |
12 |
CRISPR/Cas13-assisted hepatitis B virus covalently closed circular DNA detection
|
Zhang, Xiangying |
|
|
16 |
2 |
p. 306-315 |
artikel |
13 |
Distinctive clinical and genetic features of lean vs overweight fatty liver disease using the UK Biobank
|
Chahal, Daljeet |
|
|
16 |
2 |
p. 325-336 |
artikel |
14 |
Drug-induced liver injury from herbal and dietary supplements: a problem in the East and West alike
|
Nash, Emily |
|
|
16 |
2 |
p. 477-478 |
artikel |
15 |
Fecal microbiota transplantation in alcohol-associated acute-on-chronic liver failure: an open-label clinical trial
|
Sharma, Anima |
|
|
16 |
2 |
p. 433-446 |
artikel |
16 |
Gender differences in the association of body composition and biopsy-proved nonalcoholic steatohepatitis
|
Fang, Da |
|
|
16 |
2 |
p. 337-347 |
artikel |
17 |
Hepatic tuberculosis: a sheep in wolf’s clothing
|
Giri, Suprabhat |
|
|
16 |
2 |
p. 473-474 |
artikel |
18 |
‘Hepatic tuberculosis: a sheep in wolf’s clothing’. Author response
|
Kale, Aditya |
|
|
16 |
2 |
p. 475-476 |
artikel |
19 |
Hepatic tuberculosis masquerading as malignancy
|
Kale, Aditya |
|
|
16 |
2 |
p. 463-472 |
artikel |
20 |
Histology activity index: a benchmark for decision making
|
Parveen, Shaheena |
|
|
16 |
2 |
p. 479 |
artikel |
21 |
Image-matching digital macro-slide—a novel pathological examination method for microvascular invasion detection in hepatocellular carcinoma
|
Yu, Hong-Ming |
|
|
16 |
2 |
p. 381-395 |
artikel |
22 |
Immune checkpoint inhibitors in chronic hepatitis B: therapy or high-risk factor for reactivation?
|
Cai, Chao |
|
|
16 |
2 |
p. 480-481 |
artikel |
23 |
Is lean non-alcoholic fatty liver disease a distinct entity?
|
Lin, Huapeng |
|
|
16 |
2 |
p. 254-256 |
artikel |
24 |
Magnetic resonance elastography and proton density fat fraction predict adverse outcomes in hepatocellular carcinoma
|
Hui, Rex Wan-Hin |
|
|
16 |
2 |
p. 371-380 |
artikel |
25 |
Management of hepatitis B virus reactivation due to treatment of COVID-19
|
Yip, Terry Cheuk-Fung |
|
|
16 |
2 |
p. 257-268 |
artikel |
26 |
MRE-based NASH score for diagnosis of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
|
Lee, Young-Sun |
|
|
16 |
2 |
p. 316-324 |
artikel |
27 |
Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysis
|
Yong, Jie Ning |
|
|
16 |
2 |
p. 269-281 |
artikel |
28 |
Sequential HBV treatment with tenofovir alafenamide for patients with chronic hepatitis B: week 96 results from a real-world, multicenter cohort study
|
Ogawa, Eiichi |
|
|
16 |
2 |
p. 282-293 |
artikel |
29 |
Serum TERT C228T is an important predictor of non-viral liver cancer with fatty liver disease
|
Akuta, Norio |
|
|
16 |
2 |
p. 412-422 |
artikel |